{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:05:12Z","timestamp":1773061512983,"version":"3.50.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/ehjqcco\/qcz027","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T19:15:16Z","timestamp":1558120516000},"source":"Crossref","is-referenced-by-count":13,"title":["Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8011-6844","authenticated-orcid":false,"given":"Guglielmo","family":"Gallone","sequence":"first","affiliation":[{"name":"Unit of Cardiovascular Interventions, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizio","family":"Armeni","sequence":"additional","affiliation":[{"name":"SDA Bocconi School of Management and CERGAS (Centre for Research on Social and Healthcare Management), Bocconi University, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Verheye","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Ziekenhuis Netwerk Antwerpen Middelheim, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierfrancesco","family":"Agostoni","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo","family":"Timmers","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Campo","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy"},{"name":"Maria Cecilia Hospital, GVM Care & Research, E.S: Health Science Foundation, Cotignola, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Ielasi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, ASST Bergamo Est, \u201cBolognini\u201d Hospital, Seriate, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Sgura","sequence":"additional","affiliation":[{"name":"Interventional Cardiology Unit, Sant\u2019Ambrogio Cardio-Thoracic Center, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5055-2917","authenticated-orcid":false,"given":"Giuseppe","family":"Tarantini","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, Policlinico Hospital, University of Modena and Reggio Emilia, Modena, Italy"},{"name":"Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3940-3072","authenticated-orcid":false,"given":"Liesbeth","family":"Rosseel","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Ziekenhuis Netwerk Antwerpen Middelheim, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Zivelonghi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Leenders","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Stella","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Tebaldi","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy"},{"name":"Maria Cecilia Hospital, GVM Care & Research, E.S: Health Science Foundation, Cotignola, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Tespili","sequence":"additional","affiliation":[{"name":"Division of Cardiology, ASST Bergamo Est, \u201cBolognini\u201d Hospital, Seriate, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianpiero","family":"D\u2019Amico","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, Policlinico Hospital, University of Modena and Reggio Emilia, Modena, Italy"},{"name":"Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Baldetti","sequence":"additional","affiliation":[{"name":"Unit of Cardiovascular Interventions, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Ponticelli","sequence":"additional","affiliation":[{"name":"Unit of Cardiovascular Interventions, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Colombo","sequence":"additional","affiliation":[{"name":"Maria Cecilia Hospital, GVM Care & Research, E.S: Health Science Foundation, Cotignola, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Giannini","sequence":"additional","affiliation":[{"name":"Maria Cecilia Hospital, GVM Care & Research, E.S: Health Science Foundation, Cotignola, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,5,24]]},"reference":[{"key":"2019061900095999100_qcz027-B1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/euhj.2001.2706","article-title":"The problem of chronic refractory angina: report from the ESC Joint Study Group on the treatment of refractory angina","volume":"23","author":"Mannheimer","year":"2002","journal-title":"Eur Heart J"},{"key":"2019061900095999100_qcz027-B2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart Disease and Stroke Statistics\u20192017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"2019061900095999100_qcz027-B3","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/eurheartj\/eht165","article-title":"Long-term survival in patients with refractory angina","volume":"34","author":"Henry","year":"2013","journal-title":"Eur Heart J"},{"key":"2019061900095999100_qcz027-B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.114.001287","article-title":"Predictors of long-term clinical endpoints in patients with refractory angina","volume":"4","author":"Povsic","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2019061900095999100_qcz027-B5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00019501-200402000-00005","article-title":"Spinal cord stimulation for refractory angina pectoris: a retrospective analysis of efficacy and cost-benefit","volume":"15","author":"Yu","year":"2004","journal-title":"Coron Artery Dis"},{"key":"2019061900095999100_qcz027-B6","first-page":"1","article-title":"The Reducer device in patients with angina pectoris: mechanisms, indications, and perspectives","author":"Konigstein","year":"2017","journal-title":"Eur Heart J"},{"key":"2019061900095999100_qcz027-B7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1402556","article-title":"Efficacy of a device to narrow the coronary sinus in refractory angina","volume":"372","author":"Verheye","year":"2015","journal-title":"N Engl J Med"},{"key":"2019061900095999100_qcz027-B8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12471-016-0862-2","article-title":"Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: a single-centre real-world experience","volume":"24","author":"Abawi","year":"2016","journal-title":"Neth Heart J"},{"key":"2019061900095999100_qcz027-B9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fcvm.2016.00042","article-title":"Percutaneous device to narrow the coronary sinus: shifting paradigm in the treatment of refractory angina? A review of the literature","volume":"3","author":"Benedetto","year":"2016","journal-title":"Front Cardiovasc Med"},{"key":"2019061900095999100_qcz027-B10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijcard.2018.06.116","article-title":"Safety and efficacy of the reducer: a multi-center clinical registry\u2014REDUCE study","volume":"269","author":"Giannini","year":"2018","journal-title":"Int J Cardiol"},{"key":"2019061900095999100_qcz027-B11","author":"Wilkins","year":"2017","journal-title":"European Cardiovascular Disease Statistics 2017"},{"key":"2019061900095999100_qcz027-B12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCOUTCOMES.108.829523","article-title":"Economic impact of angina after an acute coronary syndrome insights from the MERLIN-TIMI 36 trial","volume":"2","author":"Arnold","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2019061900095999100_qcz027-B13","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/heart.89.8.848","article-title":"The current cost of angina pectoris to the National Health Service in the UK","volume":"89","author":"Stewart","year":"2003","journal-title":"Heart"},{"key":"2019061900095999100_qcz027-B14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle Angina questionnaire: a new functional status measure for coronary artery disease","volume":"25","author":"Spertus","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"2019061900095999100_qcz027-B15"},{"key":"2019061900095999100_qcz027-B16","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease\u2014addenda","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"2019061900095999100_qcz027-B17","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780190492939.001.0001","volume-title":"Cost-Effectiveness in Health and Medicine","author":"Neumann","year":"2016","edition":"2nd ed."},{"key":"2019061900095999100_qcz027-B18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"2019061900095999100_qcz027-B19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/0272989X10386800","article-title":"Predicting EQ-5D utility scores from the Seattle Angina Questionnaire in coronary artery disease: a mapping algorithm using a Bayesian framework","volume":"31","author":"Wijeysundera","year":"2011","journal-title":"Med Decis Making"},{"key":"2019061900095999100_qcz027-B20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/CEOR.S63187","article-title":"Conversion of the Seattle Angina questionnaire into EQ-5D utilities for ischemic heart disease: a systematic review and catalog of the literature","volume":"6","author":"Wijeysundera","year":"2014","journal-title":"Clin Outcomes Res"},{"key":"2019061900095999100_qcz027-B21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","article-title":"Dutch tariff for the five-level version of EQ-5D","volume":"19","author":"Versteegh","year":"2016","journal-title":"Value Heal"},{"key":"2019061900095999100_qcz027-B22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0140-6736(99)08113-1","article-title":"Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial","volume":"354","author":"Burkhoff","year":"1999","journal-title":"Lancet"},{"key":"2019061900095999100_qcz027-B23","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(00)03203-7","article-title":"Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial","volume":"356","author":"Oesterle","year":"2000","journal-title":"Lancet"},{"key":"2019061900095999100_qcz027-B24","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/eurheartj\/ehx178","article-title":"Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial","volume":"38","author":"Khan","year":"2017","journal-title":"Eur Heart J"},{"key":"2019061900095999100_qcz027-B25","year":"2003"},{"key":"2019061900095999100_qcz027-B26"},{"key":"2019061900095999100_qcz027-B27","year":"2016"},{"key":"2019061900095999100_qcz027-B28","first-page":"1","author":"Cleemput","year":"2012"},{"key":"2019061900095999100_qcz027-B29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF03320660","article-title":"Proposta di linee guida per la valutazione economica degli interventi sanitari in Italia","volume":"11","author":"Fattore","year":"2009","journal-title":"PharmacoEconomics Italian Res Articles"},{"key":"2019061900095999100_qcz027-B30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/hec.985","article-title":"Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra","volume":"14","author":"Claxton","year":"2005","journal-title":"Health Econ"},{"key":"2019061900095999100_qcz027-B31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0002-9149(99)00387-2","article-title":"Direct myocardial revascularization and angiogenesis\u2013how many patients might be eligible?","volume":"84","author":"Mukherjee","year":"1999","journal-title":"Am J Cardiol"},{"key":"2019061900095999100_qcz027-B32","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/ccd.22431","article-title":"Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortality","volume":"75","author":"Williams","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"2019061900095999100_qcz027-B33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/clc.22395","article-title":"Enhanced external counterpulsation is cost-effective in reducing hospital costs in refractory angina patients","volume":"38","author":"Lawson","year":"2015","journal-title":"Clin Cardiol"},{"key":"2019061900095999100_qcz027-B34","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcin.2018.01.251","article-title":"Coronary sinus Reducer implantation for the treatment of chronic refractory angina: a single-center experience","volume":"11","author":"Giannini","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2019061900095999100_qcz027-B35","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.4244\/EIJ-D-18-00102","article-title":"Coronary Sinus Reducer implantation improves symptoms, ischemia and physical capacity in patients with refractory angina unsuitable for myocardial revascularization: a single center experience","volume":"14","author":"Konigstein","year":"2018","journal-title":"EuroIntervention"},{"key":"2019061900095999100_qcz027-B36","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.cjca.2011.10.015","article-title":"Patients with coronary artery disease unsuitable for revascularization: definition, general principles, and a classification","volume":"28","author":"Jolicoeur","year":"2012","journal-title":"Can J Cardiol"},{"key":"2019061900095999100_qcz027-B37","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ccd.22583","article-title":"Refractory myocardial angina and determinants of prognosis","volume":"75","author":"Kornowski","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"2019061900095999100_qcz027-B38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ahj.2007.12.005","article-title":"Clinical and research issues regarding chronic advanced coronary artery disease Part II: trial design, outcomes, and regulatory issues","volume":"155","author":"Jolicoeur","year":"2008","journal-title":"Am Heart J"}],"container-title":["European Heart Journal - Quality of Care and Clinical Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjqcco\/advance-article-pdf\/doi\/10.1093\/ehjqcco\/qcz027\/28839845\/qcz027.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T05:40:37Z","timestamp":1721281237000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article\/doi\/10.1093\/ehjqcco\/qcz027\/5498149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,24]]},"references-count":38,"URL":"https:\/\/doi.org\/10.1093\/ehjqcco\/qcz027","relation":{},"ISSN":["2058-5225","2058-1742"],"issn-type":[{"value":"2058-5225","type":"print"},{"value":"2058-1742","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,24]]},"article-number":"qcz027"}}